200mg Nexavar Sorafenib Tablets About
Introducing the new 200mg Nexavar Sorafenib Tablets-a champion in advanced anticancer therapy. Designed for value and optimal efficacy, these top-tier tablets contain sterling Sorafenib tosylate as the primary ingredient. Packaged in a robust white box with red accents, each pack includes 120 premium, light yellow, film-coated tablets-each meticulously crafted for precision dosage and reliable oral administration. This lofty solution is indicated for pancreatic cancer, hepatocellular carcinoma, and renal cell carcinoma, and remains odorless for patient comfort, while offering a shelf life of 24 months. Available from leading exporters, suppliers, and traders across India.
Commercial Application & Competitive Edge
200mg Nexavar Sorafenib Tablets are expertly utilized within hospitals, specialty clinics, and cancer care centers. Designed for advanced anticancer therapy, they deliver consistent performance in treating pancreatic, liver, and kidney cancers. The product stands out due to its oral multi-kinase inhibitor action, top-value salt composition, and champion efficacy. Enhanced stability, reliable shelf life, and ease of storage elevate its reputation among oncologists and medical facilities nationwide, ensuring a lofty position in pharmaceutical oncology supply.
Supply Chain Excellence & Purchase Experience
Boasting a premium supply ability, these tablets are readily available for swift handover across the main domestic market in India. Purchase orders are met with prompt processing and secure packaging. Flexible payment terms simplify transactions, assuring healthcare providers timely access to this value-driven, sterling anticancer solution. Commitment to quality, reliability, and industry-leading standards strengthens buyer confidence and nurtures longstanding partnerships within the medicinal distribution sector.
FAQ's of 200mg Nexavar Sorafenib Tablets:
Q: How should 200mg Nexavar Sorafenib Tablets be administered?
A: These tablets are formulated for oral administration. They should be taken according to the physician's prescription, with adherence to recommended dosing schedules for optimal therapeutic results.
Q: What types of cancer are Nexavar Sorafenib Tablets primarily indicated for?
A: Nexavar Sorafenib Tablets are indicated for the treatment of pancreatic cancer, hepatocellular carcinoma (liver cancer), and renal cell carcinoma (kidney cancer), providing multi-kinase inhibition in advanced oncology protocols.
Q: When can patients expect to receive their Nexavar tablets after purchasing?
A: Upon placement of a purchase order, supply is prioritized for rapid handover and prompt shipment. Delivery timelines may vary but are generally expedited to meet the needs of the main domestic markets.
Q: Where are these tablets primarily exported and distributed?
A: These tablets are supplied by leading exporters, suppliers, and traders, with a significant presence in the Indian market and outreach to international healthcare providers as needed.
Q: What are the key benefits of using these Sorafenib tablets?
A: The top benefits include targeted oral anticancer therapy, convenient dosing, extended shelf life, and a sterling safety profile. The tablets are championed for their efficacy and ease of storage below 30C.
Q: How should the tablets be stored to ensure maximum efficacy?
A: To maintain their quality and effectiveness, store the tablets below 30C in a dry environment, away from moisture and direct sunlight. Always keep the box securely closed.
Send Inquiry
